Urolift & HTA from NICE

The National Institute for Health and Care Excellence (NICE)

NICE developed Medical Technologies Guidance (MTG26) on Urolift- a urethral lift implant for treating benign prostatic hyperplasia (BPH). 

The guidance found that the technology relieves the symptoms of BPH, reduces the length of a person's stay in hospital, and leads to cost savings to the NHS of up to £286 per patient. The technology went from being used in 4 hospitals to 15 within 6 months of guidance publication.

Visit the NICE website to read the case study in full https://www.nice.org.uk/about/what-we-do/our-programmes/nice-guidance/medical-technologies-guidance/evaluating-a-technology-urolift-case-study